☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Duchenne muscular dystrophy
Disease of the Month: Duchenne Muscular Dystrophy (DMD)
September 29, 2022
Santhera and ReveraGen Report Results of Vamorolone in P-IIb VISION-DMD Study for Duchenne Muscular Dystrophy
June 1, 2021
Sarepta's SRP-9001 Demonstrates Robust Expression and Safety Results in ENDEAVOR Study for DMD
May 19, 2021
FibroGen Initiates P-III LELANTOS-2 Study of Pamrevlumab for Duchenne Muscular Dystrophy
March 17, 2021
Sarepta Reports Mixed Results of SRP-9001 (rAAVrh74.MHCK7.micro-dystrophin) in Part 1 of Study 102 for DMD
January 8, 2021
Santhera Halts P-III SIDEROS Study Evaluating Puldysa in Patients with DMD
October 6, 2020
Load more...
Back to Home